跳至主要内容
临床试验/CTRI/2012/06/002711
CTRI/2012/06/002711尚未招募2 期

Pharmaceutical Standardization of Shadguna Bali Jarita Rasasindura and its efficacy on Madhumeha (Diabetes Mellitus)

Institute for postgraduate teaching and research in Ayurveda0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients having Ayurvedic & modern symptomatology of Madhumeha (NIDDM) will be selected from O.P.D. and I.P.D. of I.P.G.T. & R.A., Hospital, Jamnagar.
  • Age group of patients will be between 30 years to 70 years.
  • Patients having FBS level >= 126 mg/dl or PPBS level >= 200 mg/dl

排除标准

  • Patients of Diabetes Mellitus receiving Insulin.
  • Patients having chronic complications of Diabetes Mellitus
  • Micro vascular: Retinopathy, Neuropathy, & Nephropathy.
  • Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease.
  • Other chronic debilitating diseases like STD etc.

研究者

发起方
Institute for postgraduate teaching and research in Ayurveda

相似试验